Gaillard, S., Broadwater, G., Andrews, W. S., Starr, M. D., Previs, R. A., Havrilesky, L. J., … Secord, A. A. (2020). Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers. In Gynecologic Oncology (Vol. 159, pp. 41–41). Elsevier BV. https://doi.org/10.1016/j.ygyno.2020.06.087

Gaillard, S., G. Broadwater, W. S. Andrews, M. D. Starr, R. A. Previs, L. J. Havrilesky, B. A. Davidson, et al. “Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers.” In Gynecologic Oncology, 159:41–41. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.06.087.

Gaillard S, Broadwater G, Andrews WS, Starr MD, Previs RA, Havrilesky LJ, et al. Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers. In: Gynecologic Oncology. Elsevier BV; 2020. p. 41–41.

Gaillard, S., et al. “Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers.” Gynecologic Oncology, vol. 159, Elsevier BV, 2020, pp. 41–41. Crossref, doi:10.1016/j.ygyno.2020.06.087.

Gaillard S, Broadwater G, Andrews WS, Starr MD, Previs RA, Havrilesky LJ, Davidson BA, Berchuck A, Yi JS, Nixon AB, Secord AA. Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers. Gynecologic Oncology. Elsevier BV; 2020. p. 41–41.